Clinical Trials are crucial steps in the process of evaluating the safety and efficacy of medical interventions, including drugs, treatments, and medical devices, before they are approved for widespread use. These trials involve rigorous testing procedures conducted on human volunteers under controlled conditions, following strict regulatory guidelines and ethical standards. Typically divided into multiple phases, clinical trials aim to systematically assess the potential benefits and risks associated with the intervention being studied. Phase I trials primarily focus on evaluating the safety and tolerability of the intervention, often involving a small number of healthy volunteers. In contrast, Phase II trials aim to gather preliminary data on the efficacy of the intervention in patients with the targeted condition. Phase III trials are larger-scale studies designed to confirm the efficacy and safety of the intervention in a diverse patient population, providing critical evidence for regulatory approval. Following regulatory approval, Phase IV trials, also known as post-marketing surveillance studies, continue to monitor the intervention's safety and effectiveness in real-world settings. Clinical trials require meticulous planning, coordination, and adherence to protocols to ensure reliable and valid results. Participation in clinical trials is voluntary, and participants must provide informed consent after receiving detailed information about the trial's objectives, procedures, and potential risks.
Title : Renewed novel biotech ideas, with bioreactor bioengineering economic impact
Murray Moo Young, University of Waterloo, Canada
Title : Improving health in over 40,000 patients: The impact of nanomedicine fighting antibiotic resistant infections
Thomas J Webster, Brown University, United States
Title : Osmotic lysis–driven Extracellular Vesicle (EV) engineering
Limongi Tania, University of Turin, Italy
Title : Evaluating cell compatibility and subcutaneous host response of silk fibroin–chitosan plug composites as potential resorbable implants
Luis Jesus Villarreal Gomez, Universidad Autonoma de Baja California, Mexico
Title : Comparative study of endo-?-1,4-mannanases from novel bacterial strains for the production of galactomanno-oligosaccharides
Shruti Saini, National Agri-food and Bio-manufacturing Institute, India
Title : Engineering Sf9 host cells with AcMNPV genes to control baculovirus infection dynamics and heterologous gene expression
Tamer Z Salem, Zewail City of Science and Technology, Egypt